Ireland
--:--IST
Recruiting Observational

Noninvasive Artificial Venous Stasis for Reperfusion in STEMI

NCT07689591 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-08-15
Last updated
2026-08-18

Condition(s) studied

STEMI - ST Elevation Myocardial Infarction

Study summary

This prospective, randomized study was designed to evaluate whether the noninvasive artificial venous stasis / RE-START procedure, administered prior to primary percutaneous coronary intervention, increases the frequency of spontaneous coronary reperfusion in the infarct-related artery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Having presented within the first 12 hours of symptom onset Being hemodynamically stable (Killip Class I-II) * STEMI diagnosis confirmed by coronary angiography * Primary PCI (percutaneous coronary intervention) scheduled * No pathology in the upper extremity that would prevent cuff application * Be capable of providing informed consent and provide consent Exclusion Criteria: * Presence of cardiogenic shock (systolic blood pressure \< 90 mmHg and Killip Class III-IV) * Cardiac arrest occurring before or after the procedure * Need for resuscitation following failed thrombolysis * History of prior coronary artery bypass surgery * Concurrent acute aortic dissection * Venous thromboembolism or pulmonary embolism * History of an acute infection within the past 7 days * Chronic kidney disease requiring erythropoietin therapy or currently undergoing hemodialysis * Presence of liver failure or a hematologic disorder * Presence of any chronic inflammatory or autoimmune disease * History of any known malignancy (cancer) * Current treatment with glibenclamide, corticosteroids, antioxidant vitamins, or cyclosporine at the time of enrollment * History of chronic (daily) alcohol consumption * Contraindications to aspirin and/or clopidogrel * Failure to confirm a STEMI diagnosis via coronary angiography * Inability to provide informed consent * Pregnancy * First 6 months postpartum Conditions in which the administration of thrombolytics is contraindicated

Primary outcome measure(s)

  • Presence of Spontaneous Coronary Reperfusion Before Primary PCI — Periprocedural
    Spontaneous coronary reperfusion will be defined as the presence of TIMI flow grade 2 or 3 in the infarct-related artery on the first diagnostic coronary angiography performed before guidewire crossing and before primary percutaneous coronary intervention

Trial sites (2)

FacilityCityRegionStatus
Firat University Elâzığ Elaziğ Recruiting
Firat University Elâzığ Merkez Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07689591 on ClinicalTrials.gov ↗ ← All trials in Turkey